GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (NAS:RCEL) » Definitions » E10

AVITA Medical (AVITA Medical) E10 : $-2.28 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is AVITA Medical E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AVITA Medical's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.730. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.28 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 11.60% per year. During the past 5 years, the average E10 Growth Rate was 13.80% per year. During the past 10 years, the average E10 Growth Rate was 15.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of AVITA Medical was 25.70% per year. The lowest was 5.50% per year. And the median was 14.30% per year.

As of today (2024-06-06), AVITA Medical's current stock price is $9.52. AVITA Medical's E10 for the quarter that ended in Mar. 2024 was $-2.28. AVITA Medical's Shiller PE Ratio of today is .


AVITA Medical E10 Historical Data

The historical data trend for AVITA Medical's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical E10 Chart

AVITA Medical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.03 -3.21 -3.02 -2.40 -2.22

AVITA Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.41 -2.34 -2.33 -2.22 -2.28

Competitive Comparison of AVITA Medical's E10

For the Medical Devices subindustry, AVITA Medical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AVITA Medical's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AVITA Medical's Shiller PE Ratio falls into.



AVITA Medical E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AVITA Medical's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.73/131.7762*131.7762
=-0.730

Current CPI (Mar. 2024) = 131.7762.

AVITA Medical Quarterly Data

per share eps CPI Adj_EPS
201406 -0.490 100.560 -0.642
201409 0.000 100.428 0.000
201412 -0.721 99.070 -0.959
201503 0.000 99.621 0.000
201506 -0.585 100.684 -0.766
201509 0.000 100.392 0.000
201512 -0.574 99.792 -0.758
201603 0.000 100.470 0.000
201606 -0.629 101.688 -0.815
201609 0.000 101.861 0.000
201612 -0.497 101.863 -0.643
201703 0.000 102.862 0.000
201706 -0.824 103.349 -1.051
201709 0.000 104.136 0.000
201712 -0.710 104.011 -0.900
201803 0.000 105.290 0.000
201806 -0.660 106.317 -0.818
201809 0.000 106.507 0.000
201812 -1.120 105.998 -1.392
201903 0.000 107.251 0.000
201906 -0.440 108.070 -0.537
201909 -0.190 108.329 -0.231
201912 -0.530 108.420 -0.644
202003 -0.710 108.902 -0.859
202006 -0.610 108.767 -0.739
202009 -0.480 109.815 -0.576
202012 -0.260 109.897 -0.312
202103 -0.260 111.754 -0.307
202106 -0.190 114.631 -0.218
202109 -0.240 115.734 -0.273
202112 -0.340 117.630 -0.381
202203 -0.380 121.301 -0.413
202206 -0.250 125.017 -0.264
202209 -0.220 125.227 -0.232
202212 -0.220 125.222 -0.232
202303 -0.370 127.348 -0.383
202306 -0.410 128.729 -0.420
202309 -0.340 129.860 -0.345
202312 -0.280 129.419 -0.285
202403 -0.730 131.776 -0.730

Add all the adjusted EPS together and divide 10 will get our e10.


AVITA Medical  (NAS:RCEL) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


AVITA Medical E10 Related Terms

Thank you for viewing the detailed overview of AVITA Medical's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


AVITA Medical (AVITA Medical) Business Description

Address
28159 Avenue Stanford, Suite 220, Valencia, Los Angeles, CA, USA, 91355
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.
Executives
James Corbett director 2 GOODYEAR, IRVINE CA 92618
Jeremy Curnock Cook director TARGETED GENETICS CORP, 1100 OLIVE WAY STE 100, SEATTLE WA 98101
David D O'toole officer: CFO 1640 MARENGO STREET, LOS ANGELES CA 90033
Donna Shiroma officer: General Counsel C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
Cary Guy Vance director 800 EAST MIDDLEFIELD RD, MOUNTAIN VIEW CA 94043
Robert Mcnamara director C/O LDR HOLDING CORPORATION, 13785 RESEARCH BOULEVARD, SUITE 200, AUSTIN TX 78750
Michael S Perry director, officer: Chief Executive Officer C/O BIOTRANSPLANT INC, 196 BOSTON AVE SUITE 2800, MEDFORD MA 02155
Suzanne Crowe director C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
Jan Stern Reed director C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015
Michael Holder officer: Chief Financial Officer 6170 RESEARCH RD., STE 103, FRISCO TX 75034
Kathy M. Mcgee officer: Chief Operating Officer C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
Sean Ekins officer: Sr. VP of Finance C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
David Mcintyre officer: Chief Financial Officer SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Damien Mcdonald director 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY
Erin Liberto officer: Chief Commercial Officer C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355